INTRANODAL TREATMENT WITH IFNΑ‐DENDRITIC CELLS AND RITUXIMAB INDUCES SYSTEMIC CLINICAL RESPONSE AND ENDOGENOUS VACCINATION AGAINST FOLLICULAR LYMPHOMA: FINAL RESULT OF A PHASE I STUDY. (12th June 2019)

• Record Type: Journal Article
• Authors: Cox, C.; Castiello, L.; Mattei, M.; Santodonato, L.; D'agostino, G.; Muraro, E.; Martorelli, D.; Lapenta, C.; Di Napoli, A.; Di Landro, F.; Cangemi, M.; Pavan, A.; Castaldo, P.; Hohaus, S.; Donati, S.; Montefiore, E.; Berdini, C.; Borgioni, S.; Carlei, D.; Monque, D.; Ruco, L.; Prosperi, D.; Tafuri, A.; Spadaro, F.; Sestili, P.; Spada, M.; Dolcetti, R.; Santini, S.; Rozera, C.; Arico', E.; Capone, I.; Belardelli, F.;
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 317
• Page End: 318
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.126_2630
• Languages: English
• ISSNs: 0278-0232